Tocilizumab in Patients With Active Rheumatoid Arthritis and Inadequate Response to Disease-modifying Antirheumatic Drugs or Tumor Necrosis Factor Inhibitors: Subanalysis of Spanish Results of an Open-label Study Close to Clinical Practice José M. Álvaro-Gracia, Antonio Fernández-Nebro, Alicia García-López, Manuel Guzmán, Francisco J. Blanco, Francisco J. Navarro, Sagrario Bustabad, Yolanda Armendáriz, José A. Román-Ivorra

Subclinical synovitis and tenosynovitis by ultrasonography (US) 7 score in patients with rheumatoid arthritis treated with synthetic drugs, in clinical remission by DAS28 Lucio Ventura-Ríos, Guadalupe Sánchez Bringas, Cristina Hernández-Díaz, Esteban Cruz-Arenas, Rubén Burgos-Vargas

Effectiveness of intravenous tocilizumab in routine clinical practice in a cohort of Costa Rican patients with rheumatoid arthritis Mauricio Cordero-Alfaro, Carlos León-Céspedes, Allan Ramos-Esquivel